Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie B Wheeler

Showing results (261-270 of 293) with videos related to

Pageof 30
Sort By:
JCO Oncology Practice|March 13, 2025
System-Level Transformations to Increase Patient Participation in Clinical TrialsNicole E Caston, Luqin Deng, Courtney P Williams, et al.
Preventive Oncology & Epidemiology|June 17, 2024
How pharmacists would design and implement a community pharmacy-based colorectal cancer screening programAustin R Waters, Katherine Meehan, Dana L Atkins, et al.
MDM Policy & Practice|May 15, 2026
Developing a Novel Values Elicitation Measure for Clinical Use in Older Adults with Hematologic Malignancies: Values-HMDaniel R Richardson, Allison M Deal, Carl J Mhina, et al.
Journal of the National Cancer Institute|October 10, 2025
Cardiovascular risk in long-term survivors of breast, prostate, colon, and rectal cancerSarah J Westvold, Jessica B Long, Jane Fan, et al.
JAMA Oncology|June 13, 2024
Home Time Among Older Adults With Acute Myeloid Leukemia Following ChemotherapyDaniel R Richardson, Xi Zhou, Katherine Reeder-Hayes, et al.
BMC Health Services Research|August 23, 2023
Primary care provider perspectives on the role of community pharmacy in colorectal cancer screening: a qualitative studyAlison T Brenner, Catherine L Rohweder, Mary Wangen, et al.
Translational Behavioral Medicine|September 27, 2023
Patient perspectives on a proposed pharmacy-based colorectal cancer screening programRenée M Ferrari, Dana L Atkins, Mary Wangen, et al.
Cancer Medicine|September 4, 2021
Provider- and patient-level predictors of oral anticancer agent initiation and adherence in patients with metastatic renal cell carcinomaLisa P Spees, Stephanie B Wheeler, Bradford E Jackson, et al.
Preventive Medicine Reports|February 18, 2017
Multilevel predictors of colorectal cancer testing modality among publicly and privately insured people turning 50Stephanie B Wheeler, Tzy-Mey Kuo, Anne Marie Meyer, et al.
Journal of Geriatric Oncology|February 7, 2022
Patient, provider, and hospital factors associated with oral anti-neoplastic agent initiation and adherence in older patients with metastatic renal cell carcinomaDeborah R Kaye, Lauren E Wilson, Melissa A Greiner, et al.
Pageof 30

Showing results (261-270 of 293) with videos related to

Sort By:
Pageof 30
JCO Oncology Practice|March 13, 2025
System-Level Transformations to Increase Patient Participation in Clinical TrialsNicole E Caston, Luqin Deng, Courtney P Williams, et al.
Preventive Oncology & Epidemiology|June 17, 2024
How pharmacists would design and implement a community pharmacy-based colorectal cancer screening programAustin R Waters, Katherine Meehan, Dana L Atkins, et al.
MDM Policy & Practice|May 15, 2026
Developing a Novel Values Elicitation Measure for Clinical Use in Older Adults with Hematologic Malignancies: Values-HMDaniel R Richardson, Allison M Deal, Carl J Mhina, et al.
Journal of the National Cancer Institute|October 10, 2025
Cardiovascular risk in long-term survivors of breast, prostate, colon, and rectal cancerSarah J Westvold, Jessica B Long, Jane Fan, et al.
JAMA Oncology|June 13, 2024
Home Time Among Older Adults With Acute Myeloid Leukemia Following ChemotherapyDaniel R Richardson, Xi Zhou, Katherine Reeder-Hayes, et al.
BMC Health Services Research|August 23, 2023
Primary care provider perspectives on the role of community pharmacy in colorectal cancer screening: a qualitative studyAlison T Brenner, Catherine L Rohweder, Mary Wangen, et al.
Translational Behavioral Medicine|September 27, 2023
Patient perspectives on a proposed pharmacy-based colorectal cancer screening programRenée M Ferrari, Dana L Atkins, Mary Wangen, et al.
Cancer Medicine|September 4, 2021
Provider- and patient-level predictors of oral anticancer agent initiation and adherence in patients with metastatic renal cell carcinomaLisa P Spees, Stephanie B Wheeler, Bradford E Jackson, et al.
Preventive Medicine Reports|February 18, 2017
Multilevel predictors of colorectal cancer testing modality among publicly and privately insured people turning 50Stephanie B Wheeler, Tzy-Mey Kuo, Anne Marie Meyer, et al.
Journal of Geriatric Oncology|February 7, 2022
Patient, provider, and hospital factors associated with oral anti-neoplastic agent initiation and adherence in older patients with metastatic renal cell carcinomaDeborah R Kaye, Lauren E Wilson, Melissa A Greiner, et al.
Pageof 30